Form 4: PACS Group Director Receives RSU Grant

Director Taylor S. Leavitt was granted 4,660 restricted stock units as part of his compensation package with PACS Group, Inc.

Summary

• Director Taylor S. Leavitt acquired 4,660 restricted stock units (RSUs) on June 10, 2026.
• Each RSU entitles the holder to one share of common stock upon vesting.
• The RSUs are scheduled to vest fully on June 10, 2027, or at the next annual meeting, whichever occurs first, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is subject to the director's continued service to the issuer.

Future Outlook

The RSUs will vest in one year, increasing the director's direct ownership stake in the company.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practice to ensure board members maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard compensation practices for publicly traded companies in the healthcare services sector.

Stakeholder Impact

• Minimal impact on shareholders as the grant represents a standard component of director compensation.

Next Steps

• Vesting of 4,660 RSUs on June 10, 2027.

Key Dates

Keywords

PACS, PACS Group, Form 4, Insider Trading, Director Compensation, Restricted Stock Units